ORIGINAL RESEARCH article
Front. Public Health
Sec. Digital Public Health
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1616368
This article is part of the Research TopicTransforming Public Health Systems in Latin America: Challenges, Innovations and Sustainable SolutionsView all articles
Telemedicine in the Clinical Care of Chagas Disease and American Cutaneous Leishmaniasis: Pilot Study in a Public Referral Hospital in Brazil
Provisionally accepted- 1Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Global Health and Tropical Medicine (GHTM-IHMT), Universidade Nova de Lisboa (UNL), Lisbon, Portugal
- 2Clinical Research and Surveillance Laboratory in Leishmaniasis, Evandro Chagas National Institute of Infectious Diseases (INI), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil
- 3Clinical Research Laboratory in Chagas Disease, Evandro Chagas National Institute of Infectious Diseases (INI), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil
- 4Health Surveillance and Immunization Research Unit (LIVS), Evandro Chagas National Institute of Infectious Diseases (INI), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil
- 5Department of Otorhinolaryngology and Ophthalmology, School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Neglected tropical diseases (NTDs) remain major public health challenge in low-and middle-income countries (LMICs), especially in rural and underserved regions. Although telemedicine has expanded globally, evidence on its implementation for individual clinical care of NTDs remains scarce. This pilot implementation study aimed to assess the feasibility and acceptability of synchronous telemedicine consultations for patients with Chagas disease (CD) and American Cutaneous Leishmaniasis (ACL) in a national reference hospital in Brazil. Methods: We conducted a mixed-methods implementation study using the Design Science Research Methodology (DSRM). The context analysis involved structured surveys with 31 health professionals and semi-structured interviews with two local managers. Patients diagnosed with CD or ACL were recruited from August to October 2024. Teleconsultations were performed via WhatsApp video calls by four specialists. Patient satisfaction was evaluated using structured questionnaires. Findings: Of the 46 patients recruited, 38 (82•6%) completed teleconsultations. Most were elderly and had no prior telehealth experience. Despite low digital literacy and education levels, 63•2% (24/38) completed the teleconsultation without assistance. High levels of satisfaction were reported: 97•4% (37/38) were satisfied and would attend future virtual visits. Participants reported the reduced travel burden and improved access to care. No major technical issues were observed. Conclusion: Synchronous telemedicine via a low-cost, widely available platform was feasible and well-accepted for clinical follow-up of CD and ACL in a Brazilian public hospital. This approach may help reduce access barriers to specialized care for NTDs. Further research should evaluate clinical outcomes and cost-effectiveness in LMIC settings.
Keywords: Chagas Disease, cutaneous leishmaniasis, Digital Health, neglected tropical diseases, Telemedicine
Received: 24 Apr 2025; Accepted: 11 Jun 2025.
Copyright: © 2025 Salvador, Oliveira, Pimentel, Lyra, Hasslocher-Moreno, de Holanda, Varela, Silveira and Valete. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Fernanda Gonçalves Ferreira Salvador Salvador, Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Global Health and Tropical Medicine (GHTM-IHMT), Universidade Nova de Lisboa (UNL), Lisbon, Portugal
Henrique Silveira, Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Global Health and Tropical Medicine (GHTM-IHMT), Universidade Nova de Lisboa (UNL), Lisbon, Portugal
Cláudia Maria Valete, Clinical Research and Surveillance Laboratory in Leishmaniasis, Evandro Chagas National Institute of Infectious Diseases (INI), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.